Pelthos Therapeutics (PTHS) EPS (Basic) Growth (1y) (2024 - 2026)
Powered by 
Analysis
Pelthos Therapeutics (PTHS) EPS (Basic) Growth (1y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.40 Bn | 620.65 Bn | 17.26 Bn | -0.10% |
| 2 | AbbVie | 446.32 Bn | 439.75 Bn | 12.70 Bn | 284.05% |
| 3 | Merck | 358.11 Bn | 350.97 Bn | 12.21 Bn | -130.68% |
| 4 | Novartis Ag | 268.22 Bn | 260.53 Bn | 11.24 Bn | -15.94% |
| 5 | Pfizer | 156.86 Bn | 145.17 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.17 Bn | 44.78 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 43.03 Bn | 43.03 Bn | - | - |
| 8 | Incyte | 24.83 Bn | 20.29 Bn | 1.57 Bn | 39.99% |
| 9 | United Therapeutics | 21.38 Bn | 18.72 Bn | 683.80 Mn | 13.91% |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn | -350.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -350.71% |
| Mar 31, 2026 | -135.74% |
| Dec 31, 2025 | -233.44% |
| Sep 30, 2025 | -81.25% |
| Jun 30, 2025 | 278.08% |
| Mar 31, 2025 | 41.20% |
| Dec 31, 2024 | 89.08% |
| Sep 30, 2024 | 79.74% |
| Jun 30, 2024 | 67.72% |
| Mar 31, 2024 | 37.21% |